ranitidine bismuth citrate drug antisecretory bactericidal action group affiliation receptor blocker pills filmcoated tablet contains ranitidine bismuth citrate mg blister pcs box blisters n dimethylamino methyl methyl thio ethyl bismuth citrateclarification needed antiulcer mediated two active ingredients ranitidine blocker receptors suppresses basal stimulated day night gastric acid secretion reducing volume secretion concentration hydrochloric acid pepsin secreted bismuth citrate vitro bactericidal effect helicobacter pylori protective effect gastric mucosa stomach ulcer duodenal ulcer including associated helicobacter pylori combination amoxicillin clarithromycin ohm ranitidine bismuth citrate may also effective coronavirus since exhibits low cytotoxicity able protect cells infection virus selectivity index several times higher remdesivir due fact inhibits activity required viral replication helicase due irreversible displacement zinc ii ions enzyme bismuth ions hypersensitivity acute porphyria chronic renal failure cc less ml min childhood years pregnancy lactation digestive system gastralgia diarrhea constipation increased activity hepatic transaminases hepatitis hepatocellular cholestatic mixed without jaundice usually reversible acute pancreatitis side cardiovascular system decrease bp bradycardia av block chest pain asystole injection part hematopoietic organs anemia leukopenia thrombocytopenia agranulocytosis pancytopenia aplasia bone marrow nervous system sensory organs headache dizziness depression hallucinations severe elderly patients impaired visual perception associated violation accommodation violation taste tremor confusion side musculoskeletal system arthralgia myalgia allergic reactions pruritus urticaria angioedema bronchospasm anaphylactic shock anaphylactoid reactions others gynecomastia men overdose symptoms neuro nephrotoxicity treatment gastric lavage symptomatic therapy ranitidine bismuth removed bloodstream hemodialysis inside regardless food intake times day morning evening treatment prevention benign gastric duodenal ulcers well eradication helicobacter pylori relief concomitant symptoms dyspepsia following combination therapy regimens used within days drugs scheme times day ranitidine bismuth citrate mg clarithromycin mg metronidazole mg amoxicillin g scheme times day ranitidine bismuth citrate mg clarithromycin mg metronidazole mg tinidazole mg scheme ranitidine bismuth citrate mg times day metronidazole mg times day tetracycline mg times day scheme times day ranitidine bismuth citrate mg tinidazole mg amoxicillin g within days drugs scheme ranitidine bismuth citrate mg times day clarithromycin mg times day scheme ranitidine bismuth citrate mg times day amoxicillin mg times day stimulate regeneration processes ulcerative diseases stomach duodenal ulcer mg day doses days treatment duodenal ulcers mg day doses weeks extended weeks necessary stomach ulcer weeks starting therapy possibility gastric ulcer malignancy excluded since ranitidine bismuth citrate mask symptoms carcinoma stomach patients mild moderate renal impairment cc least ml min require dose adjustment elderly patients cc ml min dose changed dose changes liver failure required since ranitidine bismuth excreted mainly kidneys h histamine receptor blockers taken hours taking itraconazole ketoconazole avoid significant decrease absorption h histamine receptor blockers counteract effects pentagastrin histamine gastric acidforming function use h blockers within hours prior test histamine receptors recommended h histamine receptor blockers suppress cutaneous reaction histamine thus resulting false negative results recommended discontinue use h histamine receptor blockers performing diagnostic skin tests detect immediate allergic skin reaction use medicines containing bismuth darkening feces blackening tongue possible drug taken food regardless food intake clarithromycin increases absorption ranitidine concentration clarithromycin plasma change combined ranitidine bismuth citrate simultaneous administration ranitidine bismuth citrate antacids absorption bismuth change medicines depress bone marrow increase risk neutropenia reduces absorption itraconazole ketoconazole due increase ph gastrointestinal tract httpsenwikipediaorgwikiranitidinebismuthcitrate